Related Experiment Video
Updated: May 15, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Vascular remodeling in pulmonary hypertension
Larissa A Shimoda1, Steven S Laurie
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD 21224, USA. shimodal@welch.jhu.edu
Pulmonary hypertension involves vascular remodeling with diverse causes. This study reviews histological changes in humans and models, focusing on key signaling pathways for potential therapeutic targets.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Medicine
- Vascular Biology
Background:
- Pulmonary hypertension (PH) is a complex, progressive disease characterized by vascular remodeling.
- Histological and pathophysiological features of PH vary, reflecting diverse underlying causes.
- Structural alterations in pulmonary arteries are central to all forms of PH.
Purpose of the Study:
- To provide an overview of histological abnormalities in human PH and preclinical models.
- To discuss insights into key signaling pathways driving pulmonary vascular remodeling.
- To highlight therapeutic targeting potential.
Main Methods:
- Review of histological findings in human PH.
- Analysis of histological data from preclinical PH models.
- Discussion of signaling pathways implicated in vascular remodeling.
Main Results:
- Characteristic vascular remodeling includes arterial stiffening, intimal/medial thickening, vaso-occlusive lesions, and smooth muscle cell proliferation/transdifferentiation.
- Animal models offer insights but do not fully replicate human pulmonary arterial hypertension.
- Key pathways like ion homeostasis, endothelin-1, serotonin, BMPs, Rho kinase, and HIF-1 are involved.
Conclusions:
- Understanding histological changes and signaling pathways is crucial for PH research.
- Cross-talk between pathways suggests complex regulatory mechanisms.
- Targeting these pathways offers potential for novel PH therapies.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction

